Gene: ZNF22
Official Full Name: zinc finger protein 22provided by HGNC
Gene Summary: Predicted to enable DNA binding activity. Predicted to be involved in odontogenesis and regulation of DNA-templated transcription. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34744 | ZNF22 Knockout cell line (HeLa) | Human | ZNF22 | 1:3~1:6 | Negative | Online Inquiry |
KO34745 | ZNF22 Knockout cell line (HCT 116) | Human | ZNF22 | 1:2~1:4 | Negative | Online Inquiry |
KO34746 | ZNF22 Knockout cell line (HEK293) | Human | ZNF22 | 1:3~1:6 | Negative | Online Inquiry |
KO34747 | ZNF22 Knockout cell line (A549) | Human | ZNF22 | 1:3~1:4 | Negative | Online Inquiry |
ZNF22 Gene Knockout Cell Lines are genetically engineered cellular models designed to facilitate the study of the Zinc Finger Protein 22 (ZNF22) gene function and regulation. This product utilizes sophisticated CRISPR-Cas9 gene editing technology to create specific knockout of the ZNF22 gene, enabling researchers to investigate the biological impact of gene modulation in a controlled environment. By deleting this critical gene, ZNF22 knockout cell lines serve as powerful tools for elucidating gene functions, signaling pathways, and disease mechanisms related to ZNF22.
The primary function of these cell lines lies in their ability to unveil the roles of ZNF22 in various physiological and pathological conditions. ZNF22, known for its involvement in transcriptional regulation, plays significant roles in cell differentiation and various cellular responses, including oncogenic transformations. Researchers can utilize these knockout cell lines to observe downstream effects on gene expression profiles, cellular proliferation, and interaction networks, thus deepening the understanding of ZNF22’s functional landscape.
With broad applications in academic research and clinical investigations, ZNF22 gene knockout cell lines are imperative in cancer research, gene therapy studies, and investigations of cellular differentiation processes. Their robust design ensures reproducibility and accuracy, making them indispensable in validating therapeutic targets and understanding the genetic underpinnings of diseases.
What sets our ZNF22 knockout cell lines apart from standard alternatives is our commitment to exceptional quality and support. Each cell line is thoroughly characterized and validated for knockout efficiency and specificity, ensuring reliable results. Moreover, our product is backed by comprehensive user guides and customer service to assist researchers in maximizing the potential of their experiments.
In the ever-evolving field of molecular biology and genetics, the ZNF22 Gene Knockout Cell Lines empower researchers and clinicians to unlock new insights into gene involvement in health and disease. Our company, a leader in genetic engineering solutions, brings extensive expertise and innovative products to accelerate research and improve outcomes in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.